Financials
Value Q1, 25Q2, 26 TTM Selling/general/admin expenses —— — Research & development —— — Operating income 173.5 M303.5 M 574.2 M Non-Operating Income, Total 5.3 M4.4 M 17.7 M Interest expense, net of interest capitalized 60.4 M62.6 M 233.8 M Non-Operating Income, excl. Interest Expenses -55.1 M-58.2 M -216.1 M Unusual income/expense —— — Pretax income 118.4 M270.3 M 383.1 M Equity in earnings —— — Taxes 23.4 M52.7 M 69.4 M Non-controlling/minority interest —— — After tax other income/expense —— — Net income before discontinued operations 87.8 M217.6 M 286.5 M Discontinued operations 7.2 M64.6 M — Net income 95 M282.2 M 358.3 M Dilution adjustment -100 K-8.4 M -8.4 M Preferred dividends 3.7 M1.5 M 12.6 M Diluted net income available to common stockholders 91.2 M272.3 M 337.3 M Basic earnings per share (Basic EPS) 1.554.61 5.69 Diluted earnings per share (Diluted EPS) 1.544.6 5.66 Average basic shares outstanding 59 M59 M — Diluted shares outstanding 59.2 M59.2 M — EBITDA -87.7 M391.2 M 524.4 M EBIT -169.1 M303.5 M 278 M Cost of revenue 342.6 M— — Other cost of goods sold —— — Depreciation & amortization (cash flow) 81.4 M87.7 M 321.3 M